OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications
Mateusz Dróżdż, Sebastian Makuch, Gabriela Cieniuch, et al.
Life Sciences (2020) Vol. 261, pp. 118296-118296
Closed Access | Times Cited: 60
Mateusz Dróżdż, Sebastian Makuch, Gabriela Cieniuch, et al.
Life Sciences (2020) Vol. 261, pp. 118296-118296
Closed Access | Times Cited: 60
Showing 26-50 of 60 citing articles:
Pseudomonas aeruginosa in Cancer Therapy: Current Knowledge, Challenges and Future Perspectives
Zheng Pang, GU Meng-di, Tong Tang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Zheng Pang, GU Meng-di, Tong Tang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Role and mechanism of IL-33 in bacteria infection related gastric cancer continuum: From inflammation to tumor progression
Yunxiao Ge, Veronica Janson, Zigang Dong, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189296-189296
Open Access
Yunxiao Ge, Veronica Janson, Zigang Dong, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189296-189296
Open Access
Research progress on ultrasound in bacteria-mediated tumor treatment
Mingjie Li, Chenke Kuang, Zhili Guo, et al.
Critical Reviews in Microbiology (2025), pp. 1-12
Closed Access
Mingjie Li, Chenke Kuang, Zhili Guo, et al.
Critical Reviews in Microbiology (2025), pp. 1-12
Closed Access
Application of bacteria-mediated gene therapy in tumor treatment
Renjie Feng, Meng Du, Zhiyi Chen
Expert Opinion on Drug Delivery (2025)
Closed Access
Renjie Feng, Meng Du, Zhiyi Chen
Expert Opinion on Drug Delivery (2025)
Closed Access
A self-guidance biological hybrid drug delivery system driven by anaerobes to inhibit the proliferation and metastasis of colon cancer
Huijuan Zhang, Yaping Wang, Mengting Li, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 6, pp. 892-907
Open Access | Times Cited: 15
Huijuan Zhang, Yaping Wang, Mengting Li, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 6, pp. 892-907
Open Access | Times Cited: 15
The intratumour microbiota and neutrophilic inflammation in squamous cell vulvar carcinoma microenvironment
Natalia Rustetska, Magdalena Szczepaniak, Krzysztof Goryca, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Natalia Rustetska, Magdalena Szczepaniak, Krzysztof Goryca, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Engineering Microorganisms for Cancer Immunotherapy
Dingkang Liu, Lichao Yu, Haibo Rong, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 18
Closed Access | Times Cited: 3
Dingkang Liu, Lichao Yu, Haibo Rong, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 18
Closed Access | Times Cited: 3
Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies
Huijie Han, Hélder A. Santos
Advanced Materials (2024)
Open Access | Times Cited: 3
Huijie Han, Hélder A. Santos
Advanced Materials (2024)
Open Access | Times Cited: 3
Nanoparticle‐Based drug delivery strategies for targeted therapy to hypoxic solid tumors
ZhouXue Wu, Junru Chen, Biqiong Wang, et al.
Chemical Engineering Journal (2024), pp. 158081-158081
Closed Access | Times Cited: 3
ZhouXue Wu, Junru Chen, Biqiong Wang, et al.
Chemical Engineering Journal (2024), pp. 158081-158081
Closed Access | Times Cited: 3
Bacterial cancer therapy: A turning point for new paradigms
M. Vijayakumar, Priya Kannappan, Nagendran Tharmalingam, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2043-2050
Closed Access | Times Cited: 12
M. Vijayakumar, Priya Kannappan, Nagendran Tharmalingam, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2043-2050
Closed Access | Times Cited: 12
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
Kyle M. Pierce, William R. Miklavcic, Kyle P. Cook, et al.
Nanomaterials (2021) Vol. 11, Iss. 11, pp. 3018-3018
Open Access | Times Cited: 15
Kyle M. Pierce, William R. Miklavcic, Kyle P. Cook, et al.
Nanomaterials (2021) Vol. 11, Iss. 11, pp. 3018-3018
Open Access | Times Cited: 15
Enhancing the Contrast of Tumor Imaging for Image-Guided Surgery Using a Tumor-Targeting Probiotic with the Continuous Expression of a Biomarker
Tianjiao Meng, Wenbo Ma, Mengyue Fan, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 28, pp. 10109-10117
Closed Access | Times Cited: 11
Tianjiao Meng, Wenbo Ma, Mengyue Fan, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 28, pp. 10109-10117
Closed Access | Times Cited: 11
Downregulation of AKT/mTOR signaling pathway for Salmonella-mediated autophagy in human anaplastic thyroid cancer
Li-Hsien Wu, Christian R. Pangilinan, Che‐Hsin Lee
Journal of Cancer (2022) Vol. 13, Iss. 11, pp. 3268-3279
Open Access | Times Cited: 11
Li-Hsien Wu, Christian R. Pangilinan, Che‐Hsin Lee
Journal of Cancer (2022) Vol. 13, Iss. 11, pp. 3268-3279
Open Access | Times Cited: 11
Bacterial Therapy of Cancer: A Way to the Dustbin of History or to the Medicine of the Future?
Larisa N. Ikryannikova, Neonila V. Gorokhovets, Darya A. Belykh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9726-9726
Open Access | Times Cited: 6
Larisa N. Ikryannikova, Neonila V. Gorokhovets, Darya A. Belykh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9726-9726
Open Access | Times Cited: 6
Remotely Controllable Engineered Bacteria for Targeted Therapy of Pseudomonas aeruginosa Infection
Yanmei Gao, Jingjing Wei, Lu Pu, et al.
ACS Synthetic Biology (2023) Vol. 12, Iss. 7, pp. 1961-1971
Closed Access | Times Cited: 6
Yanmei Gao, Jingjing Wei, Lu Pu, et al.
ACS Synthetic Biology (2023) Vol. 12, Iss. 7, pp. 1961-1971
Closed Access | Times Cited: 6
Recent advances in biological membrane-based nanomaterials for cancer therapy
Mengling Shen, Xiaojie Wu, Minqian Zhu, et al.
Biomaterials Science (2022) Vol. 10, Iss. 20, pp. 5756-5785
Closed Access | Times Cited: 8
Mengling Shen, Xiaojie Wu, Minqian Zhu, et al.
Biomaterials Science (2022) Vol. 10, Iss. 20, pp. 5756-5785
Closed Access | Times Cited: 8
Effects of chemotherapy and immunotherapy on microbial diversity in TME and engineered bacterial-mediated tumor therapy
Heng Zheng, Xianxian Chen, Qiyang Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Heng Zheng, Xianxian Chen, Qiyang Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Human anaerobic microbiome: a promising and innovative tool in cancer prevention and treatment by targeting pyruvate metabolism
Hari Om, Umesh Chand, Pramod Kumar Kushawaha
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 3919-3930
Open Access | Times Cited: 4
Hari Om, Umesh Chand, Pramod Kumar Kushawaha
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 3919-3930
Open Access | Times Cited: 4
Rheology, In Vitro Digestion and Functional Properties of Sagittaria sagittifolia L. Resistant Starch as Affected by Different Preparation Methods
Yuqin Feng, Igbokwe Chidimma Juliet, Qin Wei, et al.
Starch - Stärke (2022) Vol. 74, Iss. 7-8
Closed Access | Times Cited: 7
Yuqin Feng, Igbokwe Chidimma Juliet, Qin Wei, et al.
Starch - Stärke (2022) Vol. 74, Iss. 7-8
Closed Access | Times Cited: 7
Bacteria-mediated cancer therapy: A versatile bio-sapper with translational potential
Miao Luo, Xiaoyu Chen, Haojin Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Miao Luo, Xiaoyu Chen, Haojin Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Therapeutic potential of Pseudomonas aeruginosa-mannose sensitive hemagglutinin (PA-MSHA) in cancer treatment
Xun Zheng, Yiqiao Fang, Xiuhe Zou, et al.
Microbial Pathogenesis (2023) Vol. 185, pp. 106422-106422
Closed Access | Times Cited: 3
Xun Zheng, Yiqiao Fang, Xiuhe Zou, et al.
Microbial Pathogenesis (2023) Vol. 185, pp. 106422-106422
Closed Access | Times Cited: 3
Virulence-attenuated Salmonella engineered to secrete immunomodulators reduce tumour growth and increase survival in an autochthonous mouse model of breast cancer
Lance B. Augustin, Liming Milbauer, Sara E. Hastings, et al.
Journal of drug targeting (2020) Vol. 29, Iss. 4, pp. 430-438
Closed Access | Times Cited: 8
Lance B. Augustin, Liming Milbauer, Sara E. Hastings, et al.
Journal of drug targeting (2020) Vol. 29, Iss. 4, pp. 430-438
Closed Access | Times Cited: 8
Advances in anti-tumor based on various anaerobic bacteria and their derivatives as drug vehicles
Daichen Song, Xiaofan Yang, Yanfei Chen, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 2
Daichen Song, Xiaofan Yang, Yanfei Chen, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 2
Des bactéries pour lutter contre les tumeurs
Solène Puechberty, Tin Hinan Lassouani, Farah Ammar, et al.
médecine/sciences (2024) Vol. 40, Iss. 6-7, pp. 573-575
Closed Access
Solène Puechberty, Tin Hinan Lassouani, Farah Ammar, et al.
médecine/sciences (2024) Vol. 40, Iss. 6-7, pp. 573-575
Closed Access
The Rational Engineered Bacteria Based Biohybrid Living System for Tumor Therapy
Chen Wang, Qiliner Feng, Si Shi, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 28
Closed Access
Chen Wang, Qiliner Feng, Si Shi, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 28
Closed Access
